Cargando…
Galactose-Modified PH-Sensitive Niosomes for Controlled Release and Hepatocellular Carcinoma Target Delivery of Tanshinone IIA
Increasing the drug tumor-specific accumulation and controlling their release is considered one of the most effective ways to increase the efficacy of drugs. Here, we developed a vesicle system that can target hepatoma and release drugs rapidly within tumor cells. This non-ionic surfactant vesicle i...
Autores principales: | Hu, Xixi, Zhang, Jun, Deng, Lulu, Hu, Hao, Hu, Junjie, Zheng, Guohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946689/ https://www.ncbi.nlm.nih.gov/pubmed/33694067 http://dx.doi.org/10.1208/s12249-021-01973-4 |
Ejemplares similares
-
Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
por: Li, Hu, et al.
Publicado: (2023) -
Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis
por: Ashour, Asmaa A, et al.
Publicado: (2021) -
Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury
por: Wang, Luting, et al.
Publicado: (2021) -
Characterization and Stability of Tanshinone IIA Solid Dispersions with Hydroxyapatite
por: Wang, Xiaopan, et al.
Publicado: (2013) -
Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011)